Ling P, Einhorn S, Anjegård I M, Brenning G, Einhorn N, Strander H
Radiumhemmet, Karolinska Hospital, Stockholm, Sweden.
Med Oncol Tumor Pharmacother. 1987;4(2):81-6. doi: 10.1007/BF02934944.
The sensitivity of primary human ovarian cancer cells to interferon (IFN) was studied in vitro by the use of a tumor cloning system in semi-solid agar. Tumor colonies were found in 37% (34/93) of the experiments with tumor cells from ascites and in 35% (6/17) of the experiments with solid tumors. The relative colony-forming ability could not be correlated to prior treatment. In 15 out of 18 patients the ascitic tumor cells were sensitive to IFN-alpha. Sensitivity was found in one test out of three with solid tumors. The sensitivity was dependent on the dose of IFN but could vary for the natural IFNs alpha and gamma. In seven patients the relation between in vitro and in vivo sensitivity of the tumor cells to IFN could be studied. Any correlation between in vitro and in vivo sensitivity could not be revealed in this small group of patients.
通过在半固体琼脂中使用肿瘤克隆系统,在体外研究了原代人卵巢癌细胞对干扰素(IFN)的敏感性。在37%(34/93)的腹水肿瘤细胞实验和35%(6/17)的实体肿瘤实验中发现了肿瘤集落。相对集落形成能力与先前治疗无关。18例患者中有15例腹水肿瘤细胞对IFN-α敏感。在三分之一的实体肿瘤检测中发现敏感。敏感性取决于IFN的剂量,但天然干扰素α和γ的敏感性可能有所不同。在7例患者中,研究了肿瘤细胞对IFN的体外和体内敏感性之间的关系。在这一小群患者中未发现体外和体内敏感性之间的任何相关性。